Drug interactions
Alogliptin-pioglitazone + Linagliptin
Severity: Moderate
Alogliptin-pioglitazone and Linagliptin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs are DPP-4 inhibitor and pioglitazone-containing combinations paired with linagliptin duplicates DPP-4 inhibition without added benefit.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Alogliptin-pioglitazone and Linagliptin interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Alogliptin-pioglitazone
Drug class
- Alogliptin-pioglitazone
- Endocrine
- Linagliptin
- Endocrine
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
